Skip to main content
39°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
COMPASS Pathways Plc - American Depository Shares
(NQ:
CMPS
)
4.410
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,736
Open
4.410
Bid (Size)
4.450 (3)
Ask (Size)
4.540 (7)
Prev. Close
4.410
Today's Range
4.410 - 4.410
52wk Range
4.050 - 12.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday
November 15, 2024
Via
Benzinga
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
November 15, 2024
President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
Performance
YTD
-50.95%
-50.95%
1 Month
-29.78%
-29.78%
3 Month
-44.88%
-44.88%
6 Month
-40.73%
-40.73%
1 Year
-27.23%
-27.23%
More News
Read More
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
November 14, 2024
Via
Benzinga
Exposures
Product Safety
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
November 13, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Top 3 Health Care Stocks You'll Regret Missing In November
November 05, 2024
Via
Benzinga
Uncovering Potential: Compass Pathways's Earnings Preview
October 30, 2024
Via
Benzinga
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
October 31, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results
October 31, 2024
Via
Benzinga
As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash
October 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 31, 2024
Via
Benzinga
Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results
October 31, 2024
Via
Benzinga
Exposures
Fossil Fuels
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
October 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 31, 2024
Via
Benzinga
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
October 31, 2024
From
Compass Pathways plc
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
October 25, 2024
Via
Benzinga
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
October 24, 2024
From
Compass Pathways plc
Via
Business Wire
Could Psilocybin Be A Game-Changer For Millions Battling Depression? New Study Says Yes
October 07, 2024
Via
Benzinga
Psilocybin Breakthrough: Study Reveals Potential Application For Body Dysmorphic Disorder
September 26, 2024
Via
Benzinga
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
September 23, 2024
From
Compass Pathfinder Limited
Via
Business Wire
Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week
September 15, 2024
Via
Talk Markets
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
Via
Benzinga
Exposures
Product Safety
Psychedelic Compound-Based Drug Stocks Portfolio -13% W/e Sept. 6th
September 10, 2024
Via
Talk Markets
Our Psychedelic Compound-Based Clinical-Stage Drug Stocks Portfolio Was Down 16% In August
September 06, 2024
Via
Talk Markets
Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
September 05, 2024
Via
Benzinga
Exposures
Product Safety
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.